Ventrolateral orbital cortex (VLO) has been found to play an important role in the regulation of neuropathic pain (NPP). As a traditional mood stabilizer, valproic acid (VPA) is currently employed in the treatment of NPP. However, whether VPA plays an analgesic role in VLO is still unknown.
To elucidate the underlying analgesic mechanism of microinjection of VPA into the VLO on spared nerve injury (SNI), an animal model of NPP.
We firstly examined the role of VPA by intraperitoneal and intral-VLO injection. Then, we accessed its role as a histone deacetylase inhibitor by intral-VLO microinjection of sodium butyrate. Finally, the GABAergic mechanism was measured through the intra-VLO microinjection of several agonists and antagonists of various GABAergic receptor subtypes.
Both intraperitoneal and intral-VLO injection of VPA attenuated SNI-induced mechanical allodynia. Microinjection of sodium butyrate, one of the histone deacetylase inhibitors, into the VLO attenuated the mechanical allodynia. Besides, microinjection of valpromide, a derivative of VPA which is a GABAergic agonist, into the VLO also attenuated allodynia. Furthermore, microinjection of picrotoxin, a GABAA receptor antagonist, into the VLO attenuated mechanical allodynia; microinjection of picrotoxin before VPA into the VLO increased VPA-induced anti-allodynia. Besides, microinjection of CGP 35348, a GABAB receptor antagonist, into the VLO attenuated allodynia; microinjection of CGP 35348 before VPA into the VLO also increased VPA-induced anti-allodynia. What is more, microinjection of imidazole-4-acetic acid (I4AA), a GABAC receptor antagonist, into the VLO enhanced allodynia; microinjection of I4AA before VPA into the VLO decreased VPA-induced anti-allodynia.
These results suggest that both the histone acetylation mechanism and GABAergic system are involved in mediating VLO-induced anti-hypersensitivity.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bialer M (2012) Why are antiepileptic drugs used for nonepileptic conditions? Epilepsia 53(Suppl 7):26–33
Bouhassira D (2019) Neuropathic pain: definition, assessment and epidemiology. Rev Neurol (Paris) 175:16–25
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63
Chebib M, Johnston GA (1999) The ‘ABC’ of GABA receptors: a brief review. Clin Exp Pharmacol Physiol 26:937–940
Cincarova L, Zdrahal Z, Fajkus J (2013) New perspectives of valproic acid in clinical practice. Expert Opin Investig Drugs 22:1535–1547
Cohen OS, Varlinskaya EI, Wilson CA, Glatt SJ, Mooney SM (2013) Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats. Int J Dev Neurosci 31:740–750
Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH, Raja SN (2017) Neuropathic pain. Nat Rev Dis Primers 3:17002
Dang YH, Zhao Y, Xing B, Zhao XJ, Huo FQ, Tang JS, Qu CL, Chen T (2010) The role of dopamine receptors in ventrolateral orbital cortex-evoked anti-nociception in a rat model of neuropathic pain. Neuroscience 169:1872–1880
Denk F, Huang W, Sidders B, Bithell A, Crow M, Grist J, Sharma S, Ziemek D, Rice AS, Buckley NJ, McMahon SB (2013) HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain. Pain 154:1668–1679
Dufour-Rainfray D, Vourc'h P, Le Guisquet AM, Garreau L, Ternant D, Bodard S, Jaumain E, Gulhan Z, Belzung C, Andres CR, Chalon S, Guilloteau D (2010) Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci Lett 470:55–59
Gill D, Derry S, Wiffen PJ, Moore RA (2011) Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev: CD009183
Hardy JR, Rees EA, Gwilliam B, Ling J, Broadley K, A'Hern R (2001) A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain. J Pain Symptom Manag 21:204–209
Huo FQ, Chen T, Lv BC, Wang J, Zhang T, Qu CL, Li YQ, Tang JS (2009) Synaptic connections between GABAergic elements and serotonergic terminals or projecting neurons in the ventrolateral orbital cortex. Cereb Cortex 19:1263–1272
Huo FQ, Huang FS, Lv BC, Chen T, Feng J, Qu CL, Tang JS, Li YQ (2010) Activation of serotonin 1A receptors in ventrolateral orbital cortex depresses persistent nociception: a presynaptic inhibition mechanism. Neurochem Int 57:749–755
Johnston GA, Chebib M, Hanrahan JR, Mewett KN (2010) Neurochemicals for the investigation of GABA(C) receptors. Neurochem Res 35:1970–1977
Khangura RK, Bali A, Jaggi AS, Singh N (2017) Histone acetylation and histone deacetylation in neuropathic pain: an unresolved puzzle? Eur J Pharmacol 795:36–42
Kukkar A, Singh N, Jaggi AS (2014) Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats. J Formos Med Assoc 113:921–928
Lapane KL, Quilliam BJ, Benson C, Chow W, Kim MS (2015) Impact of noncancer pain on health-related quality of life. Pain Pract 15:333–342
Lin H, Geng X, Dang W, Wu B, Dai Z, Li Y, Yang Y, Zhang H, Shi J (2012) Molecular mechanisms associated with the antidepressant effects of the class I histone deacetylase inhibitor MS-275 in the rat ventrolateral orbital cortex. Brain Res 1447:119–125
Malcangio M (2018) GABAB receptors and pain. Neuropharmacology 136:102–105
Qu CL, Tang JS, Jia H (2006) Involvement of GABAergic modulation of antinociception induced by morphine microinjected into the ventrolateral orbital cortex. Brain Res 1073-1074:281–289
Reis GM, Duarte ID (2007) Involvement of chloride channel coupled GABA(C) receptors in the peripheral antinociceptive effect induced by GABA(C) receptor agonist cis-4-aminocrotonic acid. Life Sci 80:1268–1273
Rosenberg G (2007) The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 64:2090–2103
Ross EL (2000) The evolving role of antiepileptic drugs in treating neuropathic pain. Neurology 55:S41–S46 discussion S54-8
Shao Q, Li Y, Wang Q, Zhao J (2015) IL-10 and IL-1beta mediate neuropathic-pain like behavior in the ventrolateral orbital cortex. Neurochem Res 40:733–739
Tadavarty R, Hwang J, Rajput PS, Soja PJ, Kumar U, Sastry BR (2015) Are presynaptic GABA-Crho2 receptors involved in anti-nociception? Neurosci Lett 606:145–150
Tang JS, Qu CL, Huo FQ (2009) The thalamic nucleus submedius and ventrolateral orbital cortex are involved in nociceptive modulation: a novel pain modulation pathway. Prog Neurobiol 89:383–389
Torrance N, Smith BH, Watson MC, Bennett MI (2007) Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin. Fam Pract 24:481–485
Wei L, Zhu YM, Zhang YX, Liang F, Barry DM, Gao HY, Li T, Huo FQ, Yan CX (2016a) Microinjection of histone deacetylase inhibitor into the ventrolateral orbital cortex potentiates morphine induced behavioral sensitization. Brain Res 1646:418–425
Wei L, Zhu YM, Zhang YX, Liang F, Jia H, Qu CL, Wang J, Tang JS, Lu SM, Huo FQ, Yan CX (2016b) Activation of alpha1 adrenoceptors in ventrolateral orbital cortex attenuates allodynia induced by spared nerve injury in rats. Neurochem Int 99:85–93
Xing B, Zhao Y, Zhang H, Dang Y, Chen T, Huang J, Luo Q (2011) Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antidepressant-like effect in the rat forced swim test. Brain Res Bull 85:153–157
Zhang S, Tang JS, Yuan B, Jia H (1998) Inhibitory effects of glutamate-induced activation of thalamic nucleus submedius are mediated by ventrolateral orbital cortex and periaqueductal gray in rats. Eur J Pain 2:153–163
This research was supported by the National Natural Science Foundation of China (NSFC No. 81771435 to Yong-hui Dang), the Natural Science Basic Research Plan in Shaanxi Province of China (No. 2016JM8078 to Yong-hui Dang), and the research project of State Key Laboratory for Manufacturing Systems Engineering (No. SKLMS 2017002).
Conflict of interest
The authors declare that they have no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Chu, Z., Liu, P., Li, X. et al. Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antinociceptive effect in a rat of neuropathic pain. Psychopharmacology (2020). https://doi.org/10.1007/s00213-020-05551-7
- Ventrolateral orbital cortex
- Neuropathic pain
- Valproic acid
- Histone deacetylase inhibitor
- GABAergic modulation